fabio cardoso borges - Epidemiology

Author Information

Fábio Cardoso Borges is associated with the National Cancer Registry and Epidemiology Research Unit at the Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, located in Lisbon, Portugal. His research is primarily focused on oncology, with a particular interest in the epidemiology and treatment outcomes of various cancers.

Research Contributions

Fábio Cardoso Borges has made significant contributions to the field of oncology through his research on the real-world effectiveness and safety of cancer therapies. His work includes studies on the effectiveness of palbociclib plus fulvestrant in advanced breast cancer, the epidemiological characteristics of chronic lymphocytic leukaemia in Portugal, and the capture of adverse events following immune and targeted therapies for melanoma. He has also explored the effectiveness and safety of pembrolizumab in treating advanced or metastatic non-small cell lung cancer and melanoma.

Aliases

Fábio Cardoso Borges is also known by the alias Fabio Cardoso Borges.

Publication and Citation Metrics

Metric Value
Number of Papers 6
Total Citation Count 16
H-index 2

Publications:

Partnered Content Networks

Relevant Topics